nan
Artificial intelligence (AI) In Hospital Operation Market Value Expansion And Long-Term Growth Outlook
The real-world evidence market has experienced significant expansion recently. It is anticipated to increase from $4.33 billion in 2025 to $5.14 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 18.7%. This growth in the preceding period can be attributed to factors such as the increasing digitization of healthcare records and the adoption of electronic health records, the rising utilization of insurance claims data for healthcare analytics, an elevated demand for clinical research in post-market surveillance, the expansion of patient registries across various disease areas, and the growing regulatory acceptance of real world data in decision making processes.
The real-world evidence market is projected to experience substantial expansion over the forthcoming years. Its valuation is anticipated to reach $10.3 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 19.0%. This projected expansion during the forecast timeframe is largely driven by factors such as the heightened incorporation of AI and machine learning into real-world evidence production, the increasing uptake of wearable and remote monitoring technologies for ongoing data acquisition, a surging need for insights into personalized and precision medicine, the proliferation of cloud-based healthcare analytics frameworks, and the expanding application of predictive and prescriptive analytics in decisions concerning regulation and reimbursement. Key trends anticipated in this period encompass the greater adoption of AI-powered real-world evidence analytics platforms aiding clinical decision-making, the enhanced integration of data from wearable and remote patient monitoring into RWE generation systems, the expanding deployment of predictive analytics for post-market surveillance and drug safety oversight, the growth of cloud-based real-world data platforms facilitating extensive healthcare data consolidation, and the broader application of machine learning models for producing regulatory-quality evidence.
Download A Free Sample Report For Comprehensive Market Insights:
Real-World Evidence Market Growth Factors Supporting Long-Term Expansion
The increasing embrace of precision medicine is anticipated to fuel the expansion of the real-world evidence market in the future. Precision medicine is defined as a healthcare strategy that tailors treatments according to unique patient attributes like genetic makeup, biological markers, and disease manifestations. Demand for precision medicine is growing, spurred by progress in identifying biomarkers and advanced molecular diagnostics, facilitating more precise categorization of respiratory ailments and guiding specific therapeutic choices. Real-World Evidence, gathered from sources such as electronic health records, patient registries, insurance claims, and data from wearables, supports precision medicine by demonstrating treatment efficacy across varied demographics and highlighting variations in patient response, safety profiles, and results, which aids in customizing therapies for individual patients. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the FDA sanctioned 16 novel personalized therapies for individuals suffering from rare diseases, representing a significant increase from the six approvals noted in 2022. Consequently, the expanding use of precision medicine is a key factor propelling the real-world evidence market’s growth.
Artificial intelligence (AI) In Hospital Operation Market Segment Analysis Highlighting Growth Areas
The real-world evidence market covered in this report is segmented –
1) By Component: Services; Data Sets; Analytics Platforms
2) By Deployment Mode: Cloud Based; On Premises
3) By Application: Drug Development And Approval; Post Market Surveillance; Market Access And Reimbursement; Clinical And Regulatory Decision Making; Pharmacovigilance
4) By End User: Pharmaceutical And Biotechnology Companies; Healthcare Providers; Contract Research Organizations; Healthcare Payers; Government And Regulatory Organizations; Medical Device Companies
Subsegments:
1) By Services: Consulting Services; Data Management Services; Data Collection Services; Regulatory Compliance Services; Clinical Research Support Services; Real World Data Integration Services; Evidence Generation Services
2) By Data Sets: Claims Data Sets; Electronic Health Records Data Sets; Patient Registry Data Sets; Patient Reported Outcome Data Sets; Wearable Device Data Sets; Genomic Data Sets; Pharmacy And Prescription Data Sets
3) By Analytics Platforms: Descriptive Analytics Platforms; Predictive Analytics Platforms; Prescriptive Analytics Platforms; Data Visualization Platforms; Machine Learning Based Analytics Platforms; Artificial Intelligence Driven Analytics Platforms; Real Time Analytics Platforms
Technological Advancements In Integrated Real-World Data Analytics Platforms Enhancing Patient-Centered Clinical Research And Drug Development
Major companies operating in the real-world evidence market are focusing on developing innovative solutions, such as integrated real-world data analytics platforms, to enhance patient-centered clinical research, regulatory decision-making, and drug development efficiency. Integrated real-world data analytics platforms are advanced digital systems that aggregate and analyze diverse healthcare data sources such as electronic health records, patient-reported outcomes, wearable device data, and clinical trial datasets, enabling researchers to generate actionable insights beyond traditional controlled clinical trials. For instance, in September 2023, Maxis Clinical Sciences, a US-based life sciences services company, launched Real-World Evidence Solutions designed to support patient-centered clinical research and drug development. The solution integrates diverse real-world data sources, including patient-reported outcomes and wearable device data, to improve data quality and patient engagement. It enables applications such as personalized medicine by supporting targeted treatment strategies, regulatory submissions by strengthening evidence packages, health economics and outcomes research (HEOR) by evaluating treatment cost-effectiveness, and drug repurposing by identifying new therapeutic uses for existing medicines.
Real-World Evidence Market Leading Companies Driving Competitive Growth
Major companies operating in the real-world evidence market are Optum Inc.; Oracle Corporation; IQVIA Holdings Inc.; ICON plc; Syneos Health Inc.; PPD (Thermo Fisher Scientific); Flatiron Health; Veeva Systems Inc.; Fortrea Holdings Inc.; Clarivate Plc; SAS Institute Inc.; Cegedim SA; Veradigm Inc.; Medpace Holdings Inc.; Merative L.P.; Parexel International; HealthCore Inc.; Datavant Inc.; oncertAI LLC; Komodo Health Inc.; Aetion Inc.; Truveta Inc.; HealthVerity Inc.; Evidation Health Inc.; OM1 Inc.; COTA Inc.; Cytel Inc.
Access The Complete Real-World Evidence Market Report:
Real-World Evidence Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the real-world evidence market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the real-world evidence market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.